Go Pro
LON:CIZ

Cizzle Biotechnology (CIZ) Share Price, News & Analysis

Cizzle Biotechnology logo
GBX 1.83 +0.13 (+7.76%)
As of 08/7/2026 11:49 AM Eastern

About Cizzle Biotechnology (LON:CIZ)

Advanced

Key Stats

Today's Range
1.75
1.83
50-Day Range
1.69
3.50
52-Week Range
1.20
3.90
Volume
5.02 million shs
Average Volume
1.63 million shs
Market Capitalization
£7.79 million
Assets Under Management
£48.98 million
Dividend Yield
3.54%
Net Expense Ratio
0.46%
Aggregate Rating
N/A

ETF Overview

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.

Cizzle Biotechnology Expenses

TypeCIZLarge Cap ETFsEquity ETFsLON ETFsAll ETFs
Management Fee0.40%0.58%0.57%0.45%0.53%
Other Expenses0.25%0.28%0.53%0.25%0.54%
Total Expense0.66%0.64%0.75%0.54%0.73%
Fee Waiver-0.20%-0.27%-0.67%-0.20%-0.68%
Net Expense0.46%0.61%0.63%0.47%0.60%
Receive CIZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cizzle Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CIZ ETF News Headlines

SpaceX is NOT the #1 IPO of 2026
A lesser known AI company is growing faster than both SpaceX and OpenAI. Its coding business reportedly grew from 500 million dollars to 2.5 billion dollars in just five months, and more than 300000 businesses now use its technology. While OpenAI reportedly lost 39 billion dollars last year, this company is projecting a 559 million dollar quarterly profit. Google, Amazon, Nvidia, Microsoft, Sequoia and Peter Thiel's Founders Fund have all reportedly backed it. A publicly traded backdoor may offer regular investors exposure before the expected IPO frenzy, no accredited status or brokerage minimums required.tc pixel
See More Headlines

CIZ ETF - Frequently Asked Questions

Cizzle Biotechnology's stock was trading at GBX 1.43 at the beginning of the year. Since then, CIZ shares have increased by 28.1% and is now trading at GBX 1.83.

Cizzle Biotechnology Holdings Plc (LON:CIZ) released its earnings results on Tuesday, May, 5th. The company reported ($0.17) earnings per share for the quarter.

Shares of CIZ stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cizzle Biotechnology investors own include Progressive (PGR), Qorvo (QRVO), TAL Education Group (TAL), Teekay Tankers (TNK), Waters (WAT), Baidu (BIDU).

Fund Details

Issuer
Victory Capital Management
Fund Name
VictoryShares Developed Enhanced Volatility Wtd ETF
Tax Classification
Regulated Investment Company
Stock Exchange
LON
Current Symbol
LON:CIZ
Inception Date
9/30/2014
Fund Manager
Mannik Dhillon, Stephen Hammers

Fund Focus

Asset Class
Equity
Benchmark
Nasdaq Victory?International 500 Long/Cash Volatility Weighted Index
Category
Size and Style
Focus
Large Cap
Development Level
Developed Markets
Region
Global Ex-U.S.
Number of Holdings
505

Fund Statistics

Assets Under Management
$48.98 million
Average Daily Volume
$9.24 thousand
Discount/Premium
0.17%

Administrator, Advisor and Custodian

Administrator
Victory Capital Management Inc.
Advisor
Victory Capital Management Inc.
Custodian
Citibank, N.A.
Distributor
Foreside Fund Services, LLC
Transfer Agent
Citibank, N.A.
Trustee
N/A
Lead Market Maker
RBC Capital Markets

Options

Optionable
N/A
Short Interest
15,600 shs

Miscellaneous

Beta
0.02
Creation Unit
50,000
Creation Fee
$4,500.00
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Top 4 CIZ Holdings

  • Federated Treasury Obligations Fund
    Holding Weight: 100.00%
  • China Common Rich Ren
    Holding Weight: 0.00%
  • Constellation Software In
    Holding Weight: 0.00%
  • EVRAZ PLC
    Holding Weight: 0.00%

CIZ Sector Exposure

CIZ Industry Exposure


This page (LON:CIZ) was last updated on 8/8/2026 by MarketBeat.com Staff.
From Our Partners